CXC ligand 13 in rheumatoid arthritis and its relation to secondary Sjögren’s syndrome

Wolfe, 1996, The natural history of rheumatoid arthritis, J Rheumatol Suppl, 44, 13 Goronzy, 2001, 209 Firesfein GS. Etiology and pathogenesis of RA. In: Ruddy S, Harris ED, Sledge CB, editors. Kelleys Textbook of Rheumatology. 6th ed. WB: Saunders; 2001: pp. 921-966. Theander, 2008, Relationship of Sjogren’s syndrome to other connective tissue and autoimmune disorders, Rheum Dis Clin Noth Am, 34, 935, 10.1016/j.rdc.2008.08.009 Segal, 2009, Primary Sjogren’s Syndrome: health experiences and predictors of health quality among patients in the United States, Health Qual life Outcomes, 27, 46, 10.1186/1477-7525-7-46 Graudal, 2000, Inflammatory patterns in rheumatoid arthritis estimated by the number of swollen and tender joints, the erythrocyte sedimentation rate, and hemoglobin: longterm course and association to radiographic progression, J Rheumatol, 27, 47 Rhodes, 2010, A genetic association study of serum acute-phase C-reactive protein levels in rheumatoid arthritis: implications for clinical interpretation, PLoS Med, 7, e1000341, 10.1371/journal.pmed.1000341 Sokka, 2009, Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35–45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States, J Rheumatol, 36, 1387, 10.3899/jrheum.080770 Kulkarni, 2008, Chemokines in lupus nephritis, Front Biosci, 13, 3312, 10.2741/2927 Ansel, 2000, A chemokine-driven positive feedback loop organizes lymphoid follicles, Nature, 406, 309, 10.1038/35018581 Rioja, 2008, Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor, Arthritis Rheum, 58, 2257, 10.1002/art.23667 Rotondi, 2007, Role of chemokines in endocrine autoimmune diseases, Endocr Rev, 28, 492, 10.1210/er.2006-0044 Kramer, 2011, CXCL13 in Sjogren’s syndrome: a novel biomarker of disease, Oral Surgery Endontol, 111, e41 Aletaha, 2010, 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Ann Rheum Dis, 69, 1580, 10.1136/ard.2010.138461 Vitali, 2002, Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American- European Consensus Group, Ann Rheum Dis, 61, 544, 10.1136/ard.61.6.554 Rupprecht, 2009, The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis, J Neuro-inflammation, 6, 42 Vermi, 2006, Role of dendritic cell-derived CXCL13 in the pathogenesis of Bartonella henselae B-rich granuloma, Blood, 107, 454, 10.1182/blood-2005-04-1342 Prevoo, 1995, Van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. “Modified disease activity scores that include twenty- eight joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis”, Arthritis Rheum, 38, 44, 10.1002/art.1780380107 Schaerli, 2000, Moser B.CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function, J Exp Med, 192, 1553, 10.1084/jem.192.11.1553 Maini, 1990, CD5+ B cells in rheumatoid arthritis and Sjogren’s syndrome, Clin Exp Rheumatol, 8, 67 Barone, 2005, Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjogren’s syndrome, Arthritis Rheum, 52, 1773, 10.1002/art.21062 Lee, 2009, Identification and characterization of a human CD5+ pre-naïve B cell population, J Immunol, 182, 4116, 10.4049/jimmunol.0803391 Hernández-Molina, 2011, Chemokine saliva levels in patients with primary Sjogren’s syndrome, associated Sjogren’s syndrome and systemic autoimmune diseases, Rheumatology, 50, 1288, 10.1093/rheumatology/ker019 Mewar, 2006, Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis, Arthritis Res Ther, 8, R128, 10.1186/ar2017 Gardiner, 2005, A potential pitfall in the use of the Disease Activity Score (DAS28) as the main response criterion in treatment guidelines for patients with rheumatoid arthritis, Ann Rheum Dis, 64, 506, 10.1136/ard.2004.025015 Matsui, 2007, Ann Rheum Dis, 66, 1221, 10.1136/ard.2006.063834 Klimiuk, 2003, Serum interleukin 6 (iL-6A) concentrations correlates with matrix metalloproteinases and their tissue inhibitors in rheumatoid arthritis, Pol Arch Med Wewn, 109, 119 Antero, 2011, Secondary Sjögren’s syndrome and disease activity of rheumatoid arthritis, Rev Assoc Med Bras, 57, 319, 10.1590/S0104-42302011000300015